Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by alleyesonmeon Feb 12, 2024 10:10pm
164 Views
Post# 35876732

RE:Question

RE:QuestionLabs Barrie facility, years past produced 30-50m$ quarterly wholesale sales ..capacity/ to produce isn't a factor, neither is wholesale bulk B2B cannabis procurement, this is how they operated prior to VIVO, and I'd imagine they still procure some flower for distillation....epidiolex sells between 1700$-2200usd which is a 100ml bottle of pure CBD oil covered by major insurers...between VIVO and LABs more than 800m has been spent...this is going to be a massive year....the U.S will approve the NDA, blockbuster, much bigger than epidiolex....trials are complete...all trials have been for aielments affecting many...much more than the rare cases of epilepsy that's generating a billion for JAZZ..p.s..Danno...I've been watching next leaf also...you read my mind.  
<< Previous
Bullboard Posts
Next >>